Enhancement of cardiovascular effects of glucagon by aminophylline

Afonso, Skoda; Hansing, Charles E.; Ansfield, Thomas J.; Berndt, Theodore B.; Rowe, George G.

doi:10.1093/cvr/6.3.235

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1978

2013

Publication Types

Select...

Article1

Other1

Book1

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The interaction of the individual drug effects when administered in combination was determined using a modification of the procedure reported by Alfonso et al (12). The combination dosage consisted of one-half of the 0.2 mg/kg dose of propranolol hydrochloride and one-half of the 5.0 mg/kg dose of quinidine sulfate.…”

mentioning

confidence: 99%

The Electrophysiological Actions of the Combination of Quinindine and Propranolol on the Dog Atrium

Korte

Nash

1978

Experimental Biology and Medicine

View full text Add to dashboard Cite

mentioning

confidence: 99%

The Electrophysiological Actions of the Combination of Quinindine and Propranolol on the Dog Atrium

Korte

Nash

1978

Experimental Biology and Medicine

View full text Add to dashboard Cite

Drug Interactions for Growth Factors and Hormones

Wang

Kakkar

2013

Pharmaceutical Sciences Encyclopedia

View full text Add to dashboard Cite

The focus of this chapter is on four recombinant growth factor products (erythropoietins, G‐CSF, KGF, and thrombopoietins) and three hormone products (glucagon,somatropin, and pegvisomant). We compiled the information related to drug interactions found in scientific publications and regulatory agency approved labeling documents. We reference U.S. prescribing information (PI) from the Drugs@FDA website and European summary of product characteristics (SPC) from the European Medicines Agency (EMA)'s website for European public assessment reports (EPARs). In addition, we gathered information from manufacturers and other interest groups that also post up‐to‐date labeling documents on their product websites.

show abstract

Pharmakologie und klinische Anwendung kreislaufwirksamer Medikamente

Tarnow¹

1983

Anaesthesie Und Kardiologie in Der Herzchirurgie

View full text Add to dashboard Cite

Enhancement of cardiovascular effects of glucagon by aminophylline

Cited by 3 publications

References 0 publications

The Electrophysiological Actions of the Combination of Quinindine and Propranolol on the Dog Atrium

The Electrophysiological Actions of the Combination of Quinindine and Propranolol on the Dog Atrium

Drug Interactions for Growth Factors and Hormones

Pharmakologie und klinische Anwendung kreislaufwirksamer Medikamente

Contact Info

Product

Resources

About